{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T02:20:52Z","timestamp":1791512452214,"version":"4.3.4"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1007\/s00259-021-05626-3","type":"journal-article","created":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T03:03:46Z","timestamp":1638327826000},"page":"1535-1543","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Machine learning in the differentiation of follicular lymphoma from diffuse large B-cell lymphoma with radiomic [18F]FDG PET\/CT features"],"prefix":"10.1007","volume":"49","author":[{"given":"F. Montes","family":"de Jesus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Mantzorou-Kyriaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X. U.","family":"Kahle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. J.","family":"de Haas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Yakar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. W. J. M.","family":"Glaudemans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Noordzij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. C.","family":"Kwee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Nijland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,12,1]]},"reference":[{"key":"5626_CR1","doi-asserted-by":"publisher","first-page":"5165","DOI":"10.1200\/JCO.2008.16.0283","volume":"26","author":"AJ Al-Tourah","year":"2008","unstructured":"Al-Tourah AJ, Gill KK, Chhanabhai M, Hoskins PJ, Klasa RJ, Savage KJ, et al. Population-based analysis of incidence and outcome of transformed Non-Hodgkin\u2019s lymphoma. J Clin Oncol. 2008;26:5165\u20139.","journal-title":"J Clin Oncol."},{"key":"5626_CR2","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1111\/j.1365-2141.2012.09054.x","volume":"157","author":"A Conconi","year":"2012","unstructured":"Conconi A, Ponzio C, Lobetti-Bodoni C, Motta M, Rancoita PMV, Stathis A, et al. Incidence, risk factors and outcome of histological transformation in follicular lymphoma. Br J Haematol. 2012;157:188\u201396.","journal-title":"Br J Haematol."},{"key":"5626_CR3","first-page":"761","volume":"134","author":"CL Freeman","year":"2019","unstructured":"Freeman CL, Kridel R, Moccia AA, Savage KJ, Villa DR, Scott DW, et al. Early progression after bendamustine-rituximab is associated with high risk of transformation in advanced stage follicular lymphoma. Blood. American Society of Hematology. 2019;134:761\u20134.","journal-title":"Blood. American Society of Hematology"},{"key":"5626_CR4","doi-asserted-by":"publisher","first-page":"2516","DOI":"10.1200\/JCO.2014.59.7534","volume":"33","author":"C Casulo","year":"2015","unstructured":"Casulo C, Byrtek M, Dawson KL, Zhou X, Farber CM, Flowers CR, et al. Early relapse of follicular lymphoma after rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone defines patients at high risk for death: an analysis from the National LymphoCare Study. J Clin Oncol. American Society of Clinical Oncology. 2015;33:2516\u201322.","journal-title":"J Clin Oncol. American Society of Clinical Oncology"},{"key":"5626_CR5","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.1200\/JCO.2006.09.3260","volume":"25","author":"S Montoto","year":"2007","unstructured":"Montoto S, Davies AJ, Matthews J, Calaminici M, Norton AJ, Amess J, et al. Risk and clinical implications of transformation of follicular lymphoma to diffuse large B-cell lymphoma. J Clin Oncol. 2007;25:2426\u201333.","journal-title":"J Clin Oncol."},{"key":"5626_CR6","doi-asserted-by":"publisher","first-page":"3272","DOI":"10.1200\/JCO.2012.48.3990","volume":"31","author":"BK Link","year":"2013","unstructured":"Link BK, Maurer MJ, Nowakowski GS, Ansell SM, MacOn WR, Syrbu SI, et al. Rates and outcomes of follicular lymphoma transformation in the immunochemotherapy era: a report from the university of Iowa\/mayo clinic specialized program of research excellence molecular epidemiology resource. J Clin Oncol. 2013;31:3272\u20138.","journal-title":"J Clin Oncol."},{"key":"5626_CR7","doi-asserted-by":"publisher","first-page":"2575","DOI":"10.1200\/JCO.2015.65.7163","volume":"34","author":"C Sarkozy","year":"2016","unstructured":"Sarkozy C, Trneny M, Xerri L, Wickham N, Feugier P, Leppa S, et al. Risk factors and outcomes for patients with follicular lymphoma who had histologic transformation after response to first-line immunochemotherapy in the PRIMA trial. J Clin Oncol. 2016;34:2575\u201382.","journal-title":"J Clin Oncol."},{"key":"5626_CR8","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1182\/blood-2015-01-621375","volume":"126","author":"ND Wagner-Johnston","year":"2015","unstructured":"Wagner-Johnston ND, Link BK, Byrtek M, Dawson KL, Hainsworth J, Flowers CR, et al. Outcomes of transformed follicular lymphoma in the modern era: a report from the national LymphoCare study (NLCS). Blood. 2015;126:851\u20137.","journal-title":"Blood."},{"key":"5626_CR9","doi-asserted-by":"crossref","unstructured":"Dreyling M, Ghielmini M, Rule S, Salles G, Ladetto M, Tonino SH, et al. Newly diagnosed and relapsed follicular lymphoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol Off J Eur Soc Med Oncol. Elsevier Ltd.; 2021;32:298\u2013308.","DOI":"10.1016\/j.annonc.2020.11.008"},{"key":"5626_CR10","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1111\/j.1600-0609.2010.01532.x","volume":"86","author":"T Papaj\u00edk","year":"2011","unstructured":"Papaj\u00edk T, Myslive\u010dek M, \u0160edov\u00e1 Z, Buri\u00e1nkov\u00e1 E, Proch\u00e1zka V, Koranda P, et al. Standardised uptake value of 18F-FDG on staging PET\/CT in newly diagnosed patients with different subtypes of non-Hodgkin\u2019s lymphoma. Eur J Haematol. 2011;86:32\u20137.","journal-title":"Eur J Haematol."},{"key":"5626_CR11","doi-asserted-by":"publisher","first-page":"325","DOI":"10.17219\/acem\/31804","volume":"24","author":"S Novelli","year":"2015","unstructured":"Novelli S, Briones J, Flotats A, Sierra J. PET\/CT assessment of follicular lymphoma and high grade B cell lymphoma - good correlation with clinical and histological features at diagnosis. Adv Clin Exp Med. 2015;24:325\u201330.","journal-title":"Adv Clin Exp Med."},{"key":"5626_CR12","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1182\/blood.2019001091","volume":"135","author":"F Mir","year":"2020","unstructured":"Mir F, Barrington SF, Brown H, Nielsen T, Sahin D, Meignan M, et al. Baseline SUVmax did not predict histological transformation in follicular lymphoma in the phase 3 GALLIUM study. Blood. 2020;135:1214\u20138.","journal-title":"Blood."},{"key":"5626_CR13","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1093\/annonc\/mdn657","volume":"20","author":"A Noy","year":"2009","unstructured":"Noy A, Sch\u00f6der H, G\u00f6nen M, Weissler M, Ertelt K, Cohler C, et al. The majority of transformed lymphomas have high standardized uptake values (SUVs) on positron emission tomography (PET) scanning similar to diffuse large B-cell lymphoma (DLBCL). Ann Oncol. 2009;20:508\u201312.","journal-title":"Ann Oncol."},{"key":"5626_CR14","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1148\/radiol.2015151169","volume":"278","author":"RJ Gillies","year":"2016","unstructured":"Gillies RJ, Kinahan PE, Hricak H. Radiomics: images are more than pictures, they Are data. Radiology. 2016;278:563\u201377.","journal-title":"Radiology."},{"key":"5626_CR15","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.2967\/jnumed.111.101733","volume":"53","author":"MA Lodge","year":"2012","unstructured":"Lodge MA, Chaudhry MA, Wahl RL. Noise considerations for PET quantification using maximum and peak standardized uptake value. J Nucl Med. 2012;53:1041\u20137.","journal-title":"J Nucl Med."},{"key":"5626_CR16","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.ejca.2011.11.036","volume":"48","author":"P Lambin","year":"2012","unstructured":"Lambin P, Rios-Velazquez E, Leijenaar R, Carvalho S, Van Stiphout RGPM, Granton P, et al. Radiomics: extracting more information from medical images using advanced feature analysis. Eur J Cancer. 2012;48:441\u20136.","journal-title":"Eur J Cancer."},{"key":"5626_CR17","doi-asserted-by":"publisher","first-page":"485","DOI":"10.5152\/dir.2019.19321","volume":"25","author":"B Ko\u00e7ak","year":"2019","unstructured":"Ko\u00e7ak B, Durmaz E\u015e, Ate\u015f E, K\u0131l\u0131\u00e7kesmez \u00d6. Radiomics with artificial intelligence: a practical guide for beginners. Diagnostic Interv Radiol. 2019;25:485\u201395.","journal-title":"Diagnostic Interv Radiol."},{"key":"5626_CR18","doi-asserted-by":"publisher","first-page":"6228","DOI":"10.1007\/s00330-020-06927-1","volume":"30","author":"H Wang","year":"2020","unstructured":"Wang H, Zhou Y, Li L, Hou W, Ma X, Tian R. Current status and quality of radiomics studies in lymphoma: a systematic review. Eur Radiol. 2020;30:6228\u201340.","journal-title":"Eur Radiol."},{"key":"5626_CR19","doi-asserted-by":"crossref","unstructured":"Lippi M, Gianotti S, Fama A, Casali M, Barbolini E, Ferrari A, et al. Texture analysis and multiple-instance learning for the classification of malignant lymphomas. Comput Methods Programs Biomed. Elsevier B.V.; 2020;185:105153.","DOI":"10.1016\/j.cmpb.2019.105153"},{"key":"5626_CR20","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1109\/JBHI.2013.2283658","volume":"18","author":"C Lartizien","year":"2014","unstructured":"Lartizien C, Rogez M, Niaf E, Ricard F. Computer-aided staging of lymphoma patients with FDG PET\/CT imaging based on textural information. IEEE J Biomed Heal Informatics. IEEE. 2014;18:946\u201355.","journal-title":"IEEE J Biomed Heal Informatics. IEEE"},{"key":"5626_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/5963607","volume":"2019","author":"Y Zhou","year":"2019","unstructured":"Zhou Y, Ma X-L, Pu L-T, Zhou R-F, Ou X-J, Tian R. Prediction of overall survival and progression-free survival by the 18 F-FDG PET\/CT radiomic features in patients with primary gastric diffuse large B-cell lymphoma. Contrast Media Mol Imaging. 2019;2019:1\u20139.","journal-title":"Contrast Media Mol Imaging."},{"key":"5626_CR22","doi-asserted-by":"publisher","first-page":"e183","DOI":"10.1016\/j.acra.2019.10.015","volume":"27","author":"K-H Lue","year":"2020","unstructured":"Lue K-H, Wu Y-F, Liu S-H, Hsieh T-C, Chuang K-S, Lin H-H, et al. Intratumor heterogeneity assessed by 18F-FDG PET\/CT predicts treatment response and survival outcomes in patients with Hodgkin lymphoma. Acad Radiol. 2020;27:e183\u201392.","journal-title":"Acad Radiol."},{"key":"5626_CR23","doi-asserted-by":"publisher","first-page":"2760","DOI":"10.1007\/s00259-019-04420-6","volume":"46","author":"ME Mayerhoefer","year":"2019","unstructured":"Mayerhoefer ME, Riedl CC, Kumar A, Gibbs P, Weber M, Tal I, et al. Radiomic features of glucose metabolism enable prediction of outcome in mantle cell lymphoma. Eur J Nucl Med Mol Imaging. 2019;46:2760\u20139.","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"5626_CR24","doi-asserted-by":"crossref","unstructured":"Boellaard R, Tatsch K, Pike LC, Testanera G, Kotzerke J, Graham MM, et al. FDG PET\/CT: EANM procedure guidelines for tumour imaging: version 2.0. Eur J Nucl Med Mol Imaging. 2015;42:328\u201354.","DOI":"10.1007\/s00259-014-2961-x"},{"key":"5626_CR25","doi-asserted-by":"publisher","first-page":"2320","DOI":"10.1007\/s00259-008-0874-2","volume":"35","author":"R Boellaard","year":"2008","unstructured":"Boellaard R, Oyen WJG, Hoekstra CJ, Hoekstra OS, Visser EP, Willemsen AT, et al. The Netherlands protocol for standardisation and quantification of FDG whole body PET studies in multi-centre trials. Eur J Nucl Med Mol Imaging. 2008;35:2320\u201333.","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"5626_CR26","first-page":"1","volume":"2010","author":"R Boellaard","year":"2013","unstructured":"Boellaard R, Willemsen A, Arends B, Visser EP. EARL procedure for assessing PET\/CT system specific patient FDG activity preparations for quantitative FDG PET\/CT studies. April. 2013;2010:1\u20133.","journal-title":"April"},{"key":"5626_CR27","doi-asserted-by":"publisher","first-page":"469","DOI":"10.2967\/jnumed.119.229724","volume":"61","author":"E Pfaehler","year":"2020","unstructured":"Pfaehler E, van Sluis J, Merema BBJ, van Ooijen P, Berendsen RCM, van Velden FHP, et al. Experimental multicenter and multivendor evaluation of the performance of PET radiomic features using 3-dimensionally printed phantom inserts. J Nucl Med. 2020;61:469\u201376.","journal-title":"J Nucl Med."},{"key":"5626_CR28","doi-asserted-by":"publisher","first-page":"122S","DOI":"10.2967\/jnumed.108.057307","volume":"50","author":"RL Wahl","year":"2009","unstructured":"Wahl RL, Jacene H, Kasamon Y, Lodge MA. From RECIST to PERCIST: evolving considerations for PET response criteria in solid tumors. J Nucl Med. 2009;50:122S\u201350S.","journal-title":"J Nucl Med."},{"key":"5626_CR29","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1148\/radiol.2020191145","volume":"295","author":"A Zwanenburg","year":"2020","unstructured":"Zwanenburg A, Valli\u00e8res M, Abdalah MA, Aerts HJWL, Andrearczyk V, Apte A, et al. The image biomarker standardization initiative: standardized quantitative radiomics for high-throughput image-based phenotyping. Radiology. 2020;295:328\u201338.","journal-title":"Radiology."},{"key":"5626_CR30","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1148\/radiol.2020191145","volume":"295","author":"A Zwanenburg","year":"2020","unstructured":"Zwanenburg A, Valli\u00e8res M, Abdalah MA, Aerts HJWL, Andrearczyk V, Apte A, et al. The image biomarker standardization initiative: Standardized quantitative radiomics for high-throughput image-based phenotyping. Radiology. 2020;295:328\u201338.","journal-title":"Radiology."},{"key":"5626_CR31","doi-asserted-by":"publisher","first-page":"e104","DOI":"10.1158\/0008-5472.CAN-17-0339","volume":"77","author":"JJM van Griethuysen","year":"2017","unstructured":"van Griethuysen JJM, Fedorov A, Parmar C, Hosny A, Aucoin N, Narayan V, et al. Computational radiomics system to decode the radiographic phenotype. Cancer Res. 2017;77:e104\u20137.","journal-title":"Cancer Res."},{"key":"5626_CR32","first-page":"2825","volume":"12","author":"F Pedregosa","year":"2011","unstructured":"Pedregosa F, Varoquaux G, Gramfort A, Michel V, Thirion B, Grisel O, et al. Scikit-learn: machine learning in python. J Mach Learn Res. 2011;12:2825\u201330.","journal-title":"J Mach Learn Res."},{"key":"5626_CR33","doi-asserted-by":"crossref","unstructured":"Schapire RE. Explaining AdaBoost. Empir Inference. Berlin, Heidelberg: Springer Berlin Heidelberg; 2013. p. 37\u201352.","DOI":"10.1007\/978-3-642-41136-6_5"},{"key":"5626_CR34","doi-asserted-by":"crossref","unstructured":"Friedman JH. Greedy function approximation: a gradient boosting machine. Ann Stat. 2001;29.","DOI":"10.1214\/aos\/1013203451"},{"key":"5626_CR35","doi-asserted-by":"crossref","unstructured":"Chen T, Guestrin C. XGBoost. Proc 22nd ACM SIGKDD Int Conf Knowl Discov Data Min. New York, NY, USA: ACM; 2016. p. 785\u201394.","DOI":"10.1145\/2939672.2939785"},{"key":"5626_CR36","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/1471-2105-12-77","volume":"12","author":"X Robin","year":"2011","unstructured":"Robin X, Turck N, Hainard A, Tiberti N, Lisacek F, Sanchez J-C, et al. pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics. 2011;12:77.","journal-title":"BMC Bioinformatics."},{"key":"5626_CR37","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1093\/annonc\/mdp030","volume":"20","author":"JYY Ngeow","year":"2009","unstructured":"Ngeow JYY, Quek RHH, Ng DCE, Hee SW, Tao M, Lim LC, et al. High SUV uptake on FDG-PET\/CT predicts for an aggressive B-cell lymphoma in a prospective study of primary FDG-PET\/CT staging in lymphoma. Ann Oncol. 2009;20:1543\u20137.","journal-title":"Ann Oncol."},{"key":"5626_CR38","doi-asserted-by":"publisher","first-page":"4643","DOI":"10.1200\/JCO.2005.12.072","volume":"23","author":"H Sch\u00f6der","year":"2005","unstructured":"Sch\u00f6der H, Noy A, G\u00f6nen M, Weng L, Green D, Erdi YE, et al. Intensity of 18fluorodeoxyglucose uptake in positron emission tomography distinguishes between indolent and aggressive non-Hodgkin\u2019s lymphoma. J Clin Oncol. 2005;23:4643\u201351.","journal-title":"J Clin Oncol."},{"key":"5626_CR39","first-page":"1790","volume":"36","author":"M Rodriguez","year":"1995","unstructured":"Rodriguez M, Rehn S, Ahlstr\u00f6m H, Sundstr\u00f6m C, Glimelius B. Predicting malignancy grade with PET in non-Hodgkin\u2019s lymphoma. J Nucl Med. 1995;36:1790\u20136.","journal-title":"J Nucl Med."},{"key":"5626_CR40","doi-asserted-by":"publisher","first-page":"3522","DOI":"10.1182\/blood.V86.9.3522.bloodjournal8693522","volume":"86","author":"M Lapela","year":"1995","unstructured":"Lapela M, Leskinen S, Minn HR, Lindholm P, Klemi PJ, S\u00f6derstr\u00f6m KO, et al. Increased glucose metabolism in untreated non-Hodgkin\u2019s lymphoma: a study with positron emission tomography and fluorine-18-fluorodeoxyglucose. Blood. 1995;86:3522\u20137.","journal-title":"Blood."},{"key":"5626_CR41","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.3324\/haematol.2019.230649","volume":"105","author":"P Strati","year":"2020","unstructured":"Strati P, Ahmed MA, Fowler NH, Nastoupil LJ, Samaniego F, Fayad LE, et al. Pre-treatment maximum standardized uptake value predicts outcome after frontline therapy in patients with advanced stage follicular lymphoma. Haematologica. 2020;105:1907\u201313.","journal-title":"Haematologica."},{"key":"5626_CR42","doi-asserted-by":"publisher","first-page":"471","DOI":"10.3324\/haematol.12013","volume":"93","author":"C Bodet-Milin","year":"2008","unstructured":"Bodet-Milin C, Kraeber-Bod\u00e9r\u00e9 F, Moreau P, Campion L, Dupas B, Le Gouill S. Investigation of FDG-PET\/CT imaging to guide biopsies in the detection of histological transformation of indolent lymphoma. Haematologica. 2008;93:471\u20132.","journal-title":"Haematologica."},{"key":"5626_CR43","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1097\/MNM.0b013e328342b9d2","volume":"32","author":"M Karam","year":"2011","unstructured":"Karam M, Feustel PJ, Vera CD, Nazeer T. Features of large cell transformation of indolent lymphomas as observed on sequential PET\/CT. Nucl Med Commun. 2011;32:177\u201385.","journal-title":"Nucl Med Commun."},{"key":"5626_CR44","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0084999","volume":"9","author":"X Wu","year":"2014","unstructured":"Wu X, Pertovaara H, Korkola P, Dastidar P, J\u00e4rvenp\u00e4\u00e4 R, Eskola H, et al. Correlations between functional imaging markers derived from PET\/CT and diffusion-weighted MRI in diffuse large B-cell lymphoma and follicular lymphoma. PLoS One. 2014;9:e84999.","journal-title":"PLoS One."},{"key":"5626_CR45","doi-asserted-by":"publisher","first-page":"488","DOI":"10.2967\/jnumed.118.222893","volume":"61","author":"ME Mayerhoefer","year":"2020","unstructured":"Mayerhoefer ME, Materka A, Langs G, H\u00e4ggstr\u00f6m I, Szczypi\u0144ski P, Gibbs P, et al. Introduction to radiomics. J Nucl Med. 2020;61:488\u201395.","journal-title":"J Nucl Med."},{"key":"5626_CR46","doi-asserted-by":"crossref","unstructured":"Rizzo S, Botta F, Raimondi S, Origgi D, Fanciullo C, Morganti AG, et al. Radiomics: the facts and the challenges of image analysis. Eur Radiol Exp. 2018;2.","DOI":"10.1186\/s41747-018-0068-z"},{"key":"5626_CR47","doi-asserted-by":"crossref","unstructured":"Ha S, Choi H, Paeng JC, Cheon GJ. Radiomics in oncological PET\/CT: a methodological overview. Nucl Med Mol Imaging (2010). 2019;53:14\u201329.","DOI":"10.1007\/s13139-019-00571-4"},{"key":"5626_CR48","doi-asserted-by":"crossref","unstructured":"Mayerhoefer ME, Riedl CC, Kumar A, Dogan A, Gibbs P, Weber M, et al. Marrow involvement in mantle cell lymphoma\u00a0: a retrospective study in 97 patients. Cancers (Basel). 2020;1\u201313.","DOI":"10.3390\/cancers12051138"},{"key":"5626_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fonc.2020.00001","volume":"10","author":"M Zhang","year":"2020","unstructured":"Zhang M, Bao Y, Rui W, Shangguan C, Liu J, Xu J, et al. Performance of 18F-FDG PET\/CT radiomics for predicting EGFR mutation status in patients with Non-small cell lung cancer. Front Oncol. 2020;10:1\u20138.","journal-title":"Front Oncol."}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-021-05626-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-021-05626-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-021-05626-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,22]],"date-time":"2022-03-22T11:07:32Z","timestamp":1647947252000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00259-021-05626-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,1]]},"references-count":49,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["5626"],"URL":"https:\/\/doi.org\/10.1007\/s00259-021-05626-3","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,1]]},"assertion":[{"value":"18 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the ethical principles of the Declaration of Helsinki and with the approval of the Medical Ethics Review Board of the UMCG (202100165, 02-03-2021). The Medical Ethics Review Board waived informed consent of all study participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors declare that they have no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}